ATE302192T1 - Trizyklische pyrol- oder pyrazolderivate - Google Patents
Trizyklische pyrol- oder pyrazolderivateInfo
- Publication number
- ATE302192T1 ATE302192T1 AT98924579T AT98924579T ATE302192T1 AT E302192 T1 ATE302192 T1 AT E302192T1 AT 98924579 T AT98924579 T AT 98924579T AT 98924579 T AT98924579 T AT 98924579T AT E302192 T1 ATE302192 T1 AT E302192T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrolen
- tricyclic
- pyrazole derivatives
- pyrazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15725597 | 1997-06-13 | ||
PCT/JP1998/002579 WO1998056768A1 (fr) | 1997-06-13 | 1998-06-11 | Derives tricycliques de pyrrole ou de pyrazole |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE302192T1 true ATE302192T1 (de) | 2005-09-15 |
Family
ID=15645662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98924579T ATE302192T1 (de) | 1997-06-13 | 1998-06-11 | Trizyklische pyrol- oder pyrazolderivate |
Country Status (18)
Country | Link |
---|---|
US (1) | US6245796B1 (de) |
EP (1) | EP0990650B8 (de) |
JP (1) | JP3410478B2 (de) |
KR (1) | KR19990006912A (de) |
CN (1) | CN1097054C (de) |
AR (1) | AR012952A1 (de) |
AT (1) | ATE302192T1 (de) |
AU (2) | AU727654B2 (de) |
BR (1) | BR9802005A (de) |
CA (1) | CA2291651A1 (de) |
DE (1) | DE69831236T2 (de) |
ES (1) | ES2246535T3 (de) |
HU (1) | HUP9801340A1 (de) |
ID (1) | ID23173A (de) |
PL (1) | PL326777A1 (de) |
RU (1) | RU2191176C2 (de) |
TW (1) | TW502024B (de) |
WO (1) | WO1998056768A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138393B2 (en) | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
WO2000008001A1 (en) * | 1998-08-07 | 2000-02-17 | Chiron Corporation | Substituted isoxazole as estrogen receptor modulators |
GB9819019D0 (en) * | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds II |
KR20010073153A (ko) | 1998-09-18 | 2001-07-31 | 제임스 에이. 아노 | 녹내장 치료용의 세로토닌성 5ht2 작용제 |
GB9918965D0 (en) | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxi |
WO2001083487A1 (fr) * | 2000-04-28 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de froindazole |
DE10055093A1 (de) * | 2000-11-07 | 2002-05-16 | Agfa Gevaert Ag | Cyaninfarbstoff |
WO2002040457A1 (en) | 2000-11-20 | 2002-05-23 | Biovitrum Ab | Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
JP2004535418A (ja) | 2001-06-01 | 2004-11-25 | アルコン,インコーポレイテッド | ピラノインダゾールおよび緑内障治療への使用 |
EP1392658A4 (de) | 2001-06-01 | 2004-10-13 | Alcon Inc | Neue kondensierte indazole und indole und deren verwendung zur behandlung von glaucom |
AU2002360819A1 (en) * | 2001-12-28 | 2003-07-24 | Bayer Corporation | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
ATE454383T1 (de) | 2002-06-19 | 2010-01-15 | Biovitrum Ab Publ | Neue verbindungen, deren verwendung und herstellung |
WO2004054572A2 (en) | 2002-12-13 | 2004-07-01 | Alcon, Inc. | Novel benzopyran analogs and their use for the treatment of glaucoma |
CL2004000826A1 (es) | 2003-04-25 | 2005-03-04 | Pfizer | Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129 |
US7476687B2 (en) | 2003-11-26 | 2009-01-13 | Alcon, Inc. | Substituted furo[2,3-g]indazoles for the treatment of glaucoma |
US7129257B1 (en) * | 2003-12-15 | 2006-10-31 | Alcon, Inc. | Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma |
US6989445B2 (en) * | 2003-12-15 | 2006-01-24 | Alcon, Inc. | Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma |
US7423056B2 (en) * | 2004-09-03 | 2008-09-09 | Athersys, Inc. | Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
EP2343303A1 (de) * | 2004-10-07 | 2011-07-13 | Boehringer Ingelheim International GmbH | PI3-Kinase Inhibitoren |
TW201118073A (en) * | 2009-10-30 | 2011-06-01 | Merck Sharp & Dohme | Hexahydrocyclopentyl [F] indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators |
EP2510949A4 (de) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | Therapeutikum für fibromyalgie |
US20130267500A1 (en) | 2010-09-01 | 2013-10-10 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
US9345703B2 (en) | 2011-09-15 | 2016-05-24 | University Of Kansas | Kappa opioid receptor effectors and uses thereof |
US8853207B2 (en) | 2012-04-12 | 2014-10-07 | Development Center For Biotechnology | Heterocyclic pyrazole compounds, method for preparing the same and use thereof |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
JP2023508908A (ja) | 2019-12-19 | 2023-03-06 | バイエル、アクチエンゲゼルシャフト | フロインダゾール誘導体 |
EP4298102A1 (de) | 2021-02-23 | 2024-01-03 | Bayer Aktiengesellschaft | Furoindazolderivate als gpr84-antagonisten |
EP4330260A1 (de) | 2021-04-29 | 2024-03-06 | Bayer Aktiengesellschaft | Furoindazolderivate als antagonisten oder inhibitoren von gpr84 |
WO2024083705A1 (en) | 2022-10-18 | 2024-04-25 | Bayer Aktiengesellschaft | Furoindazole derivatives for the treatment of pain |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5637984B2 (de) * | 1974-01-31 | 1981-09-03 | ||
TW270114B (de) * | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
TW334423B (en) | 1993-10-22 | 1998-06-21 | Hoffmann La Roche | Tricyclic 1-aminoethylpyrrole-derivatives |
GB9326192D0 (en) * | 1993-12-22 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
EP0763034A1 (de) | 1994-05-28 | 1997-03-19 | Smithkline Beecham Plc | Amid-derivate mit 5ht1d-antagonistischer wirkung |
TW403738B (en) * | 1994-08-12 | 2000-09-01 | Hoffmann La Roche | Tricyclic pyrazole derivatives |
-
1998
- 1998-06-03 AU AU69893/98A patent/AU727654B2/en not_active Ceased
- 1998-06-05 TW TW087108930A patent/TW502024B/zh not_active IP Right Cessation
- 1998-06-10 AR ARP980102731A patent/AR012952A1/es unknown
- 1998-06-10 PL PL98326777A patent/PL326777A1/xx not_active Application Discontinuation
- 1998-06-11 WO PCT/JP1998/002579 patent/WO1998056768A1/ja active IP Right Grant
- 1998-06-11 AU AU76740/98A patent/AU7674098A/en not_active Abandoned
- 1998-06-11 EP EP98924579A patent/EP0990650B8/de not_active Expired - Lifetime
- 1998-06-11 US US09/445,104 patent/US6245796B1/en not_active Expired - Fee Related
- 1998-06-11 CA CA002291651A patent/CA2291651A1/en not_active Abandoned
- 1998-06-11 ES ES98924579T patent/ES2246535T3/es not_active Expired - Lifetime
- 1998-06-11 AT AT98924579T patent/ATE302192T1/de not_active IP Right Cessation
- 1998-06-11 JP JP50209799A patent/JP3410478B2/ja not_active Expired - Fee Related
- 1998-06-11 DE DE69831236T patent/DE69831236T2/de not_active Expired - Lifetime
- 1998-06-11 RU RU98111511/04A patent/RU2191176C2/ru not_active IP Right Cessation
- 1998-06-12 KR KR1019980021848A patent/KR19990006912A/ko not_active Application Discontinuation
- 1998-06-12 BR BR9802005A patent/BR9802005A/pt not_active IP Right Cessation
- 1998-06-12 CN CN98114746A patent/CN1097054C/zh not_active Expired - Fee Related
- 1998-06-12 HU HU9801340A patent/HUP9801340A1/hu unknown
- 1998-11-06 ID IDW991587A patent/ID23173A/id unknown
Also Published As
Publication number | Publication date |
---|---|
DE69831236T2 (de) | 2006-04-13 |
EP0990650B1 (de) | 2005-08-17 |
US6245796B1 (en) | 2001-06-12 |
CN1097054C (zh) | 2002-12-25 |
EP0990650A4 (de) | 2002-02-13 |
WO1998056768A1 (fr) | 1998-12-17 |
EP0990650A1 (de) | 2000-04-05 |
JP3410478B2 (ja) | 2003-05-26 |
AU6989398A (en) | 1998-12-17 |
TW502024B (en) | 2002-09-11 |
ID23173A (id) | 2000-03-23 |
CN1203234A (zh) | 1998-12-30 |
HUP9801340A1 (hu) | 1999-11-29 |
CA2291651A1 (en) | 1998-12-17 |
AU7674098A (en) | 1998-12-30 |
KR19990006912A (ko) | 1999-01-25 |
RU2191176C2 (ru) | 2002-10-20 |
AU727654B2 (en) | 2000-12-21 |
PL326777A1 (en) | 1998-12-21 |
ES2246535T3 (es) | 2006-02-16 |
DE69831236D1 (de) | 2005-09-22 |
HU9801340D0 (en) | 1998-08-28 |
BR9802005A (pt) | 2000-03-21 |
EP0990650B8 (de) | 2005-10-19 |
AR012952A1 (es) | 2000-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE302192T1 (de) | Trizyklische pyrol- oder pyrazolderivate | |
NO20012219D0 (no) | Tricykliske pyrazolderivater | |
ATE360618T1 (de) | Pyrazolderivate | |
EE9900211A (et) | Asendatud pürasooliderivaadid | |
DE69719547D1 (de) | Parasitizide pyrazolderivate | |
ATE260243T1 (de) | N-aroylphenylalaninderivate | |
ATE235220T1 (de) | Resorcinderivate | |
ID22781A (id) | Turunan-turunan nikotinamida | |
DE69817186D1 (de) | Diaminorhodamin-derivate | |
DE69735712D1 (de) | Aryl-pyrimidin-derivate | |
ATE261942T1 (de) | 6-phenylpyridinderivate | |
PT915088E (pt) | Derivados de d-prolina | |
NO981946D0 (no) | Imidazoquinazolin-derivater | |
ATE255098T1 (de) | Substituierte chromanderivate | |
DE69732576D1 (de) | Tetrahydrobenzindolon-derivate | |
PT1003719E (pt) | Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida | |
PT1027362E (pt) | Derivados de cetolidos 2-halogeno-6-o-substituidos | |
ATE255099T1 (de) | Substituierte chromanderivate | |
DE69841086D1 (de) | 5-Deoxy-Cytidin-Derivate | |
ATE239018T1 (de) | Pyrazol-derivate | |
EE9900182A (et) | 2-metoksüfenüülpiperasiini derivaadid | |
DE69829682D1 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate | |
DE69828780D1 (de) | Amidinocamptpthecin-derivate | |
NO981495D0 (no) | Phenoxymetylpiperidin-derivater | |
BR9604847A (pt) | Derivados de pirazol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |